GHK-Cu stimulates the creation of hyaluronic acid and glycosaminoglycans which attract water and lock in moisture, leaving skin well-hydrated, smooth, plump, firm and youthful
Tirzepatide (Mounjaro/Zepbound) Primary uses: Weight loss (more effective than semaglutide) Type 2 diabetes Appetite control Typical dosing: Week 1-4: 2.5mg once weekly Week 5-8: 5mg once weekly Week 9-12: 7.5mg once weekly Week 13-16: 10mg once weekly Week 17-20: 12.5mg once weekly Week 21+: 15mg once weekly (max) Administration: Subcutaneous injection, once weekly Special notes: Dual GLP-1/GIP agonist Slightly better weight loss than semaglutide FDA-approved Similar side effects to semaglutide AOD 9604 (Fragment 176-191) Primary uses: Fat loss (especially stubborn fat) No appetite suppression Body recomposition Typical dosing: 300-600mcg daily Fasted morning injection preferred Duration: 12-16 weeks Administration: Subcutaneous injection Special notes: Fragment of growth hormone (fat-burning portion only) No effect on blood sugar or insulin Targets stubborn fat areas Good for athletes who can't suppress appetite Learn more in our AOD 9604 guide and HGH Fragment calculator
However, people who are at risk of deficiency will probably need to take supplements
The position of the tubes should be alternated daily (left to right)
While N-Acetyl Selank Amidate is expected to have similar effects with potentially greater magnitude thanks to its enhanced pharmacokinetics, there is no data to confirm this, save for anecdotal reports
